Scancell
SEARCH
  • HOME
  • COMPANY
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • NEWS
  • HOME
  • COMPANY
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US

News

Scancell at the frontier of cancer therapy

The Shares magazine August 2019 Spotlight profile of Scancell. Click here to view.

Shares Magazine August 2019 Spotlight

 

Friday 30 August 2019 17:00 Categories: Immunobody Moditope News Year - 2019

2019 Preliminary Results

To download click here

Tuesday 20 August 2019 13:00 Categories: News Regulatory News Year - 2019

Scancell Holdings lays groundwork for pivotal year

A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D.

[View article]

Tuesday 20 August 2019 13:00 Categories: Media Coverage News SCIB1 Year - 2019

Notice of AGM

To download click here

Tuesday 20 August 2019 09:00 Categories: News Regulatory News Year - 2019

Scancell to begin UK arm of phase II skin cancer trial ‘immediately’

Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date.

[View article]

Monday 19 August 2019 13:00 Categories: Media Coverage News SCIB1 Year - 2019

Scancell back in the clinic with a phase II trial of its flagship skin cancer treatment

[View interview]

Monday 19 August 2019 13:00 Categories: Interviews Media Coverage News SCIB1 Year - 2019

Scancell SCIB1 Study Update

To download click here

Monday 19 August 2019 13:00 Categories: News Regulatory News SCIB1 Year - 2019

Shares Magazine Investor Presentation

At the Forefront of Immuno-Oncology

The Shares Magazine Investor Evening presentation from 17 July 2019 is now available. Click here to view.

 

To review further documents and presentations, please click here.

Wednesday 17 July 2019 13:00 Categories: Immunobody Modi-1 Moditope News Presentations SCIB1 Year - 2019

Scancell on verge of recruiting patients with advanced melanoma for UK clinical trials

The immunotherapy specialist gave an update on progress for a “busy and productive” half-year.

[View article]

Monday 1 July 2019 13:00 Categories: Media Coverage Modi-1 News Year - 2019

Scancell H1 2019 Business Update

To download click here

Monday 1 July 2019 13:00 Categories: News Regulatory News Year - 2019
  • Page 5 of 33
  • 
  • 
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 20
  • 30
  • 
  • 

Categories

  • AvidiMab (9)
  • Covid-19 (7)
  • Immunobody (111)
  • Interviews (10)
  • Media Coverage (40)
  • Modi-1 (37)
  • Modi-2 (4)
  • Moditope (75)
  • News (282)
  • Presentations (5)
  • Regulatory News (253)
  • SCIB1 (134)
  • SCIB2 (21)
  • Webcasts (1)
  • Year - 2014 and older (142)
  • Year - 2015 (15)
  • Year - 2016 (31)
  • Year - 2017 (21)
  • Year - 2018 (42)
  • Year - 2019 (47)
  • Year - 2020 (30)
  • Company
  • Overview
  • Board of Directors
  • Management
  • Clinical Advisory Board
  • Partnerships
  • Technology
  • Immunobody
  • Moditope
  • AvidiMab
  • Scientific Papers & Posters
  • Products
  • Product Pipeline
  • SCIB1
  • SCIB2
  • Modi-1
  • Modi-2
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2021